STRUCTURAL BASIS FOR FUNCTIONAL DIVERSITY OF BETA-1-ADRENERGIC, BETA-2-ADRENERGIC AND BETA-3-ADRENERGIC RECEPTORS

被引:81
作者
EMORINE, LJ
FEVE, B
PAIRAULT, J
BRIENDSUTREN, MM
MARULLO, S
DELAVIERKLUTCHKO, C
STROSBERG, DA
机构
[1] CNRS,IMMUNOPHARMACOL MOLEC LAB,F-75674 PARIS 14,FRANCE
[2] UNIV PARIS 07,INST COCHIN GENET MOLEC,F-75674 PARIS 14,FRANCE
关键词
D O I
10.1016/0006-2952(91)90188-B
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:853 / 859
页数:7
相关论文
共 48 条
[1]   THE BROWN ADIPOCYTE BETA-ADRENOCEPTOR [J].
ARCH, JRS .
PROCEEDINGS OF THE NUTRITION SOCIETY, 1989, 48 (02) :215-223
[2]   AN M2 MUSCARINIC RECEPTOR SUBTYPE COUPLED TO BOTH ADENYLYL CYCLASE AND PHOSPHOINOSITIDE TURNOVER [J].
ASHKENAZI, A ;
WINSLOW, JW ;
PERALTA, EG ;
PETERSON, GL ;
SCHIMERLIK, MI ;
CAPON, DJ ;
RAMACHANDRAN, J .
SCIENCE, 1987, 238 (4827) :672-675
[3]   GENE-REGULATION BY STEROID-HORMONES [J].
BEATO, M .
CELL, 1989, 56 (03) :335-344
[4]   CLONING, NUCLEOTIDE-SEQUENCE, AND POTENTIAL REGULATORY ELEMENTS OF THE GLUTAMINE-SYNTHETASE GENE FROM MURINE 3T3-L1 ADIPOCYTES [J].
BHANDARI, B ;
BECKWITH, KD ;
MILLER, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :5789-5793
[5]   AGONIST AND ANTAGONIST CHARACTERIZATION OF A PUTATIVE ADRENOCEPTOR WITH DISTINCT PHARMACOLOGICAL PROPERTIES FROM THE ALPHA-SUBTYPES AND BETA-SUBTYPES [J].
BOND, RA ;
CLARKE, DE .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (03) :723-734
[6]  
BOUSQUET P, 1984, J PHARMACOL EXP THER, V230, P232
[7]   REMOVAL OF PHOSPHORYLATION SITES FROM THE BETA-2-ADRENERGIC RECEPTOR DELAYS ONSET OF AGONIST-PROMOTED DESENSITIZATION [J].
BOUVIER, M ;
HAUSDORFF, WP ;
DEBLASI, A ;
ODOWD, BF ;
KOBILKA, BK ;
CARON, MG ;
LEFKOWITZ, RJ .
NATURE, 1988, 333 (6171) :370-373
[9]   AN INVESTIGATION OF THE BETA-ADRENOCEPTOR THAT MEDIATES METABOLIC RESPONSES TO THE NOVEL AGONIST BRL28410 IN RAT SOLEUS MUSCLE [J].
CHALLISS, RAJ ;
LEIGHTON, B ;
WILSON, S ;
THURLBY, PL ;
ARCH, JRS .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (05) :947-950
[10]  
CHEUNG AH, 1989, MOL PHARMACOL, V34, P132